Back
CytoMed Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
GDTC
CytoMed Therapeutics
Last Price:
2.20
Seasonality Move:
-35.48%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is relatively stagnant and GDTC is experiencing slight buying pressure.
CytoMed Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Buy |
| 20-day SMA: | 2.3 | Sell |
| 50-day SMA: | 2.07 | Buy |
| 200-day SMA: | 2.03 | Buy |
| 8-day EMA: | 2.19 | Buy |
| 20-day EMA: | 2.24 | Buy |
| 50-day EMA: | 2.13 | Buy |
| 200-day EMA: | 2.22 | Buy |
CytoMed Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 51.08 | Buy |
| Chaikin Money Flow: | 1065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.13 - 2.63) | Sell |
| Bollinger Bands (100): | (1.56 - 2.28) | Buy |
CytoMed Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytoMed Therapeutics Stock
Is CytoMed Therapeutics Stock a Buy?
- CytoMed Therapeutics share price is 2.26 while GDTC 8-day simple moving average is 2.14, which is a Buy signal.
- The stock price of GDTC is 2.26 while CytoMed Therapeutics 20-day SMA is 2.30, which makes it a Sell.
- CytoMed Therapeutics 50-day simple moving average is 2.07 while GDTC share price is 2.26, making it a Buy technically.
- GDTC stock price is 2.26 and CytoMed Therapeutics 200-day simple moving average is 2.03, creating a Buy signal.
GDTC Technical Analysis vs Fundamental Analysis
Buy
62
CytoMed Therapeutics (GDTC)
is a Buy
Is CytoMed Therapeutics a Buy or a Sell?
-
CytoMed Therapeutics stock is rated a Buy
The current CytoMed Therapeutics [GDTC] share price is $2.26. The Score for GDTC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
CytoMed Therapeutics Stock Info
Market Cap:
26.07M
Price in USD:
2.26
Share Volume:
2.69K
CytoMed Therapeutics 52-Week Range
52-Week High:
5.50
52-Week Low:
1.20
Buy
62
CytoMed Therapeutics (GDTC)
is a Buy
CytoMed Therapeutics Share Price Forecast
-
What is the CytoMed Therapeutics stock price today?
The CytoMed Therapeutics stock price is 2.26 USD today. -
Will GDTC stock go up or go down?
CytoMed Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is CytoMed Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytoMed Therapeutics is not overvalued.
Is CytoMed Therapeutics Stock a Buy?
- CytoMed Therapeutics share price is 2.26 while GDTC 8-day exponential moving average is 2.19, which is a Buy signal.
- The stock price of GDTC is 2.26 while CytoMed Therapeutics 20-day EMA is 2.24, which makes it a Buy.
- CytoMed Therapeutics 50-day exponential moving average is 2.13 while GDTC share price is 2.26, making it a Buy technically.
- GDTC stock price is 2.26 and CytoMed Therapeutics 200-day simple moving average is 2.22, creating a Buy signal.
Fundamental Analysis of CytoMed Therapeutics
Is CytoMed Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
Technical Analysis of CytoMed Therapeutics
Should I short CytoMed Therapeutics stock?
- GDTC Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting CytoMed Therapeutics is a Sell
- CytoMed Therapeutics Relative Strength Index (RSI) is 51.08, which suggest CytoMed Therapeutics is overbought
- The Bollinger Bands (25) for CytoMed Therapeutics is (2.13 - 2.63), which suggest CytoMed Therapeutics is a Buy
- The Bollinger Bands (100) for CytoMed Therapeutics is (1.56 - 2.28), which suggest CytoMed Therapeutics is a Buy
* CytoMed Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.